How plant species loss affects human health: A conversation with Cassandra Quave

Changing rainfall patterns, extreme weather events, ocean acidification: climate change is threatening species across the globe—many of which were already under pressure from other human activity. What will happen as plant species get displaced, become fewer, or disappear altogether? Could this have ramifications for human health?

This question led me to Dr. Cassandra Quave, an associate professor of dermatology and human health at Emory School of Medicine. Her research group documents the uses of botanical ingredients in traditional medicine in different sites across the globe and investigates the pharmacology of those medicines to understand what chemical constituents are responsible for their activities. Her team asks, “Is this particular herb safe? Is it effective for X, Y, or Z uses?” They then communicate their findings back to communities and use the findings as a starting point for new-drug development, primarily for infectious and inflammatory diseases. This work has taken her to the Amazon, the Balkans, the Mediterranean, and North Africa and has led to more than 130 scientific publications about the findings.

I sat down with Dr. Quave to discuss the important role medicinal plants play in protecting human health, including combating antibiotic resistance, and the threat climate change poses to these plants—and our future.

The following interview has been edited for length and clarity.

Dr. Cassandra Quave is an associate professor of dermatology and human health at Emory School of Medicine and Emory’s herbarium curator. She teaches courses on medicinal plants, microbiology, and pharmacology and leads natural-product drug discovery research. In her award-winning science memoir, The Plant Hunter, Dr. Quave tells the story of her personal medical journey and her quest to find new ways to fight illness and disease with plants. Dr. Quave’s research has been featured in many publications, including National Geographic Magazine, The New York Times, NPR, and PBS.

Annie Mullowney: Where did your passion for medicinal plants, food, and health come from?

Cassandra Quave: I was a pre-med student in college, very focused on trying to become an orthopedic surgeon. A lot of that was motivated by my personal experiences with surgeries throughout childhood to address my numerous congenital abnormalities in my skeletal system. I’ve had more than two dozen orthopedic surgeries in my lifetime to help correct my spine, hip, and leg.

But then I started to become more and more interested in the field of anthropology. I had an opportunity when I was finishing my junior year in college to work as a volunteer at a research camp in the Amazon on the Sucusari tributary off the Napo River. I worked with a local healer, Don Antonio, and had my eyes opened to the reality of medical care in developing countries and the heavy reliance on traditional medicines. I also saw that, in many ways, traditional medicines were being displaced by Western medicine, despite those Western medicines often being inadequate—in terms of both supply and local knowledge of how to access and use those medicines.

That experience got me really interested in—instead of being a physician and prescribing drugs—discovering new drugs. And better understanding the intersection between global health and future medical discoveries.

Annie Mullowney: Did you ever feel a push-pull between studying Western medicine and traditional medicines?

Cassandra Quave: I had a very classic focus on hard science and evidence-based medicine from a young age, both from my own experiences and through the many years I spent working in the emergency department in my hometown as a teen. So when I was doing that initial work in the Amazon, there were certainly things that I couldn’t quite understand or explain that in retrospect make a lot of sense.

For example, there was a tree called “sangre de drago” or the “dragon’s blood tree.” Don Antonio would use this tree for a number of different ailments or issues, and he kept emphasizing how it was a really powerful medicine. Years later, a formula of a mixture of compounds from that tree was the second FDA-approved botanical drug. When you put science behind it, oftentimes there are real, rational reasons why people continue to use these different medicines.

I think even a lot of physicians forget where many of our drugs come from. If you look, for example, at the World Health Organization’s list of essential medicines—medicines that are necessary to have in a primary care center—there’s a large list of molecules that were originally discovered in medicinal plants that have a history of use in traditional medicine. Digoxin, a heart drug, came from the foxglove—a use that goes back to William Withering in the 1700s. In the 1800s, morphine, which comes from the pod of the opium poppy, became one of the first drugs to have its chemical structure elucidated for pain. But it wasn’t until the 1960s that the National Cancer Institute started doing more searches for cancer medications from plants. And that helped to create more of the key drugs that are still used today, including paclitaxel, which you may know as Taxol, and camptothecin, which led to the development of topotecan.

I think about what I’m doing as bridging the gap between traditional medicine—where you may have spirituality, ritual, or other magical beliefs—and the chemistry that explains it.

Annie Mullowney: If you have a headache, are you reaching for an over-the-counter drug or something herbal?

Cassandra Quave: If it is a sinus headache, my go-to is Advil Cold & Sinus. This is ibuprofen plus pseudoephedrine, which is a molecule originally discovered in the ephedra plant. So I see it as a plant-based medicine. I also drink herbal tea. I drink mint tea for soothing a stomachache. I use all the things in my arsenal, and you’ll see the same in a lot of healers. There’s this idea that traditional medicine and modern medicine, which is built on the backbone of traditional medicine, have to be in opposition. I don’t see them as opposing at all. I see them as being a continuous line.

Annie Mullowney: Let’s talk about antibiotic resistance. What role do you see for nature in combating it?

Cassandra Quave: Antibiotic resistance is the major threat to medicine as we know it today. Without the ability to manage infections, our ability to provide care during childbirth, during cancer treatment, during even minor surgical procedures is going to be more limited. As of 2019, an estimated 700,000 people were dying annually due to untreatable infections. This is projected to reach 10 million a year by mid-century. It’s going to take a multitude of options to solve this problem.

Antibiotics are, in many cases, natural products. They were derived from microbes that were making these compounds to defend themselves or attack other organisms in their environment. What we’re trying to do is leverage our ability to read the language of nature and take the bits of that language that can offer humans the best defense against these microbial pathogens.

Classic antibiotics work by targeting the growth and survival of bacteria. The work that we’ve been doing has led to the discovery of molecules that don’t actually inhibit the growth or survival of the bacteria but instead act by limiting their ability to do harm. We think that this approach may be less likely to lead to antibiotic resistance because when you have a direct pressure on an organism, that organism will evolve, so you have progeny that’s resistant to that drug. We’re taking a side-door approach to diminish the ability of these microbes to cause harm.

And we’ve had a lot of success—for example, in our work on antibiotic-resistant Staphylococcus aureus or staph infections. You may also know of it as MRSA. These are drug-resistant staph, and we’ve been able to shut down their ability to communicate. Bacterial cells need to communicate with each other to coordinate their activities, so by shutting their communications down, we’ve also been able to stop their production of toxic molecules that destroy our tissues and lead to more severe infections.

So when I think about how plants might help us in the fight against antibiotic resistance, it might not be individual compounds from plants. Nature doesn’t always work through single molecules. It could be cocktails of compounds from plants or combinations of plant-derived compounds with other existing antibiotics to make the antibiotics that we have remaining work better.

Annie Mullowney: Could you talk more about the link between your work and climate change? Is it affecting our ability to create new drugs, fight antibiotic resistance, and generally to promote good health around the world?

Cassandra Quave: Climate change is putting a strain on plant populations across the globe. And as a result, the billions of people in economically developing countries that rely on medicinal plants as their only source of medicine are going to face greater and greater challenges in accessing medical care of their cultural traditions.

I’ve seen this already—because of climate change but also just the expansion of human populations. The global population has surpassed eight billion people, meaning our footprint is expanding into more and more land areas. And more land is being used for agriculture—mainly soy and corn and palm oil products that are going into processed foods, into animal feed. So there are a lot of pressures faced in many different sectors that are putting more of these wild plants under threat.

Jan Salick, who has done amazing work in the Himalayas, has shown that a lot of plants are moving further and further up the mountains. After a while, you run out of mountain, and that’s a direct response to climate change.

Annie Mullowney: What do you wish the general public and businesses and policymakers understood about the links between health and nature? What actions should we be taking now for a healthier future?

Cassandra Quave: Health is complicated, and a lot of this is not in the control of our day-to-day choices. But I encourage people to get better connected to their own environment: maybe it’s as simple as learning the names of some of the trees in your neighborhood or doing some gardening. I feel very strongly that you are not going to advocate for nature if you have no relationship with the natural world.

We can also make choices with our spending, considering the damage certain products have on the world. I mentioned palm oil before. I’ve been to Sumatra. I’ve seen the territories where the forests have been ripped out and there’s hardly any habitat left. The local communities are losing the resources they need to survive and thrive in that forest.

We at LEFF are, at heart, storytellers. We are dedicated to amplifying voices and causes from all over the world, regardless of gender orientation, race, or economic background. And the stories we tell as part of the Into the Weeds interview series are particularly important to us. We will be interviewing inspiring individuals whose work contributes to the achievement of the United Nation Sustainable Development Goals (SDGs) at every level; we’ll bring you insights from the leaders of global organizations, renowned experts and academics, and innovative local businesses.

Our goal for this series is the same one that underpins all of LEFF Sustainability Group’s client work: to use our storytelling skills to build awareness of the issues that threaten our planet and to draw attention to all the people, initiatives, and innovations that are fighting back.

But I think a lot of progress will have to come from government-initiated regulations and policies. For example, I would upend the entire Farm Bill. This is a post–World War II policy that emphasizes production of commodity crops by subsidizing corn, soy, and other crops. It’s the reason soda is cheaper than a health beverage or water. And it’s affecting our health. It’s also affecting our environment: the Amazon is being plowed down to plant more soy.

Another place to start would be to help restore what would be called “traditional knowledge” in another culture. Most people in the United States don’t know how to grow their own food. We should invest in educational programs to teach kids today not only how to better manage finances and make healthy food choices but also how to grow foods. This way people can supplement their diet with some fresh fruits and vegetables or, at a minimum, herbs.

If I could wave a magic wand, it would be to help people understand how our health as a species is tied to the health of our planet. We cannot have one without the other.


Behind the scenes

This interview is part of LEFF’s Into the Weeds interview series—a series that amplifies individuals whose work contributes to the achievement of the SDGs at every level. We’ll be bringing you insights from renowned experts and the leaders of global organizations and innovative local businesses. Annie Mullowney (she/her) is a senior editor for LEFF, and Clair Myatt (she/her) is the manager of LEFF’s Sustainability Group, for which Katie Parry (she/her) is the director.

Comments and opinions expressed by interviewees are their own and do not represent or reflect the opinions, policies, or positions of LEFF or have its endorsement.

 

Senior adviser

Allan elevates thought leadership with a veteran editor’s perspective on distinctive content and a journalist’s eye for trends in world events. He began his career as a writer and editor covering business, economics, and the environment for the Tallahassee Democrat, the Miami Herald, The New York Times, and The International Herald Tribune in Paris. Allan went on to work at McKinsey & Company for more than 20 years in Europe, Asia, and North America, where he specialized in emerging markets and shaped global thought leadership as editor in chief and editorial board member of the McKinsey Quarterly. At LEFF, Allan works with colleagues and clients to launch new projects, and he uses his expertise to support the professional development of LEFF’s team of editors.

 

Director of LEFF Sustainability Group

Katie is passionate about the power of storytelling to motivate audiences to action, particularly related to environmental issues—the throughline of her multifaceted career. She has managed a water project for the World Bank, been one of the UK’s climate security negotiators at NATO, helped design green strategies for several governments as a McKinsey & Company consultant, and taught courses on writing for public policy at the Harvard Kennedy School. Based in Brussels, Katie currently develops sustainable content strategies; edits a wide range of climate content, including infographics and major reports; and oversees LEFF’s Into the Weeds interview series, which shares stories of the people and organizations combating climate change.

 

VP of marketing and business development

Chad has brought brand narratives to life for more than 15 years by developing powerful stories, inspiring stakeholders with unique marketing campaigns, and building communities of enthusiastic audiences. Chad honed his approach to content as a sales and marketing executive for Disney and ESPN Media Networks, where he used storytelling to increase revenue for mobile and linear-channel products. Since then, he has held several senior marketing roles across healthcare, education, and technology companies. Most recently, Chad was the vice president of corporate marketing at Telarus, where he developed comprehensive branding initiatives across multiple technology disciplines, including cloud, cybersecurity, and AI. Chad joined LEFF in 2024, and he’s excited to launch innovative marketing strategies that drive growth and deliver transformative results.

Senior adviser

Mary is a data visualization expert with a rare combination of talents. Trained as a fine artist, she also enjoys writing, advanced math, and learning new skills; she taught herself coding and UX, and she’s continued to build valuable proficiencies that keep her on the cutting edge of content. Prior to joining LEFF, Mary worked at McKinsey & Company, developing the precise, engaging charts that have become a hallmark of the firm’s widely read publications. Today, she collaborates with LEFF editors and clients to distill even the most complex ideas into compelling, intuitive data visualizations. By asking the right questions and determining the best formats, she ensures data visuals amplify key insights.

Senior adviser

Peter is an expert at developing clear, compelling stories about complex subjects—a skill that’s served him well as an award-winning journalist, editor, and book author. A former reporter for The Wall Street Journal and writer for Fortune magazine, Peter also spent seven years at the McKinsey Global Institute, where he stayed at the forefront of major trends in business and technology as a senior editor and editorial director. Peter has also written five nonfiction books, including a bestseller in France, where he currently resides. He brings his unique perspective as a collaborative, tactical thought partner to his work at LEFF by uniting stakeholders, upholding a high standard of quality, and ensuring content is well-structured and aligned with client needs.

People director

Tracy built her career in people operations by developing a wide range of skills; because of her many capabilities, she refers to herself as the “Swiss army knife of HR.” But Tracy’s work goes beyond typical human resources functions: She’s committed to elevating the complete employee experience. She draws on her work across industries—including roles at Rockwell Automation, Harley-Davidson, and the American Medical Association—to promote a workplace culture of openness and acceptance, and she’s guided by her empathic nature and willingness to embrace a challenge. In everything from implementing new processes for feedback and evaluation and supporting employees through times of great change, Tracy makes LEFF a special place to work by ensuring that everyone feels welcome, valued, and seen.

 

Design director

Christa was always drawn to art and design, and over time, she also discovered a passion for progress: She’s motivated by meeting goals, building teams, and refining the many small steps between concept and content. Christa built the foundation of her design career at an advertising agency before moving on to the marketing department of a healthcare university, where she oversaw print and digital projects as a graphic designer, senior creative and brand specialist, and creative services manager. Today, Christa is excited to explore the possibilities of LEFF’s ever-growing content offerings, lead a group of creative designers, and use her experience and strategic design thinking to deliver outstanding results for clients. 

 

Production director

Jen approaches copy with a clear philosophy: Edit in service of the reader. She began her career in journalism, where editing newspaper copy on the second shift meant meeting tight daily deadlines and making quick decisions. Roles as a senior editor, executive editor, and director of editorial production followed, and Jen used her good judgment and love for the written word to elevate copy for entertainment news and B2B publications. Whether navigating the intricacies of highly specialized style guides or constructing crosswords in her free time, Jen is at home in the possibilities of language. At LEFF, she leads the production department: a collaborative, adaptable team that maintains our—and Jen’s—deep commitment to quality and clarity.

 

Group account director

Joe values preparation, but an early career experience taught him to troubleshoot in unfamiliar situations. One of his first roles in marketing required him to travel suddenly to Toronto to help a multinational restaurant business build its presence in Canada. Two years later, Joe had worked through regional differences and complex logistics to help the client meet its goals, and he became a more active listener in the process. Whether successfully delivering game-changing outcomes in an agency setting or at a university, where he directed marketing operations across campuses, Joe remains focused on solving problems with well-informed decisions. At LEFF, he’s overseeing the processes that ensure everyone has what they need to do their best work and strengthening the connection between effective operations and exceptional client service.

VP, content marketing

Karianne has a unique history of engaging audiences and telling stories. After studying music, she found new ways to express herself in the world of branding. Her more than 20 years in marketing and strategy are a testament to her ability to bridge business and creative mindsets, and she has developed content to communicate the ethos of global brands such as GE, State Farm, Motorola, and Procter & Gamble. Prior to joining LEFF in 2024, Karianne was vice president of digital at Weber Shandwick, led workshops at General Assembly, founded her own business, became a certified well-being expert, and released an album. As the lead of LEFF’s content marketing team, she looks forward to helping clients discover new opportunities to make an impact with lively, thoughtful content.

SVP, content innovation

Luke has crafted a writing life by pursuing—and creating—fresh opportunities. As a newspaper journalist in his native Australia and then as a foreign correspondent, freelance writer, editor, and management consultant, Luke developed the keen editorial eye and strategic perspective that has led him to the forefront of thought leadership and B2B publishing. Luke has helped leading organizations share transformative insights through print media and emerging digital platforms. Before joining LEFF, he was an executive editor at McKinsey & Company, managing director of Deloitte Insights, and global editor in chief for EY. Always driven to match the medium to the message, Luke collaborates with LEFF’s content marketing, editorial, and design departments to showcase clients’ most important ideas.

Partner

Alia approaches content like a conversation: She listens to clients to learn about their goals and responds with strategies that resonate with their audiences. Alia is an expert at translating ideas into smart, compelling integrated campaigns, and her experience in the agency world honed her abilities as a versatile creative partner and insightful innovator for enterprise clients such as Toyota, Kaiser Permanente, and Allstate. She got her start in publishing after living and working in Ukraine, where she focused on HIV/AIDS education and grant writing. At LEFF, she has assembled a team of multifaceted creatives who tell clients’ exciting, meaningful stories across channels and formats.